CARE study reports complete regression of liver cancer in a child treated with novel immunotherapy
September 10, 2026
September 10, 2026
HOUSTON, Texas, Sept. 10 -- The Baylor College of Medicine posted the following news:
* * *
CARE study reports complete regression of liver cancer in a child treated with novel immunotherapy
*
A new report in the New England Journal of Medicine by researchers at Baylor College of Medicine, Texas Children's Hospital and Seattle Children's describes a complete regression of hepatoblastoma, the most common pediatric liver cancer, in a 3- . . .
* * *
CARE study reports complete regression of liver cancer in a child treated with novel immunotherapy
*
A new report in the New England Journal of Medicine by researchers at Baylor College of Medicine, Texas Children's Hospital and Seattle Children's describes a complete regression of hepatoblastoma, the most common pediatric liver cancer, in a 3- . . .